Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01122953 | Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer, Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting Conditions | PHASE1 | COMPLETED | 34 | — | — | Apr 1, 2010 | Jun 1, 2010 | Jan 27, 2021 | 1 | Mexico |
| Arm | Type | Description |
|---|---|---|
| Phenytoin | EXPERIMENTAL | - |
| Epamin | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Phenytoin | DRUG | Single dose of Phenytoin 125 mg/5 ml suspension made by Laboratorios Pfizer, S.A. de C.V. |
| Epamin | DRUG | Single dose Epamin 125 mg/5 ml suspension made by McNeil LA LLC |
Inclusion Criteria: * Healthy male and/or female subjects between the ages of 18 and 55 years * Body Mass Index (BMI) of 18 to 26.9 kg/m2 or ± 10% variation of the ideal weight; and a total body weight \>50 kg (110 lbs). * An informed consent document signed and dated by the subject or a legally ac...